AlphaYouCT
Insider selling
Cameron Turtle sold $1.3M of Spyre Therapeutics, Inc. (SYRE) stock
Cameron Turtle, Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE), sold 15,000 shares of SYRE stock worth $1.3M, per an SEC Form 4 filed Sep 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 3 days before it was made public.
SYRE has moved +4.0% since the trade date, from $88.50 to $92.03 (Sep 21, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 3 days
- Price since
- +4.0%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More SYRE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.